Neurology

The Role of Emerging Therapeutics to Reduce Impairment and Improve Quality of Life for Patients With Early Alzheimer’s Disease
http://academiccme.com/wp-content/uploads/2017/08/AD-Image-wpcf_80x80.jpg
This CME program will highlight content presented at the Alzheimer’s Association International Conference 2017 held in London, England…
Webcast
AAN 2017: Clinical Updates on Novel Receptor Modulator Therapeutics for the Management of Patients with Relapsing Multiple Sclerosis
http://academiccme.com/wp-content/uploads/2017/05/iStock-611992272-wpcf_80x80.jpg
This CME program will highlight recent scientific advances in the management and treatment of patients with relapsing multiple sclerosis presented at the American Academy of Neurology 2017 Annual Meeting in Boston, Massachusetts…
Post Conference Review and Analysis
AAN 2017: Optimizing the Quality of Life in Patients with Parkinson’s Disease
http://academiccme.com/wp-content/uploads/2017/06/iStock-610655566-wpcf_80x80.jpg
This CME activity will include data presented at the 69th Annual American Academy of Neurology Meeting held in Boston, Massachusetts from April 22 – 28, 2017…
Post Conference Review and Analysis
Applying New Science to Improve Outcomes for Patients with Multiple Sclerosis
http://academiccme.com/wp-content/uploads/2017/05/AAN-125-x-125-wpcf_80x80.jpg
This CME program will feature content presented at the the 69th Annual American Academy of Neurology Meeting held in Boston, Massachusetts…
Meeting Reporter
A Closer Look at S1P Immunomodulator Therapeutics to Improve Outcomes in Patients with Relapsing Multiple Sclerosis
http://academiccme.com/wp-content/uploads/2017/03/Image-for-ACTRIMS-Brochure-wpcf_80x80.png
This CME webcast was derived from content presented at a live symposium at the Advanced Curriculum for Multiple Sclerosis 2017 held in Orlando, Florida…
Webcast